Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
12.60    -0.05 (-0.40%)
Bid:
12.60
Ask:
12.95
Spread: 0.35 (2.778%)
Market Cap: £42.85m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

AGM Statement and Trading Upd

16 Jun 2008 07:00

RNS Number : 6694W
BATM Advanced Communications Ld
16 June 2008
 



 

BATM Advanced Communications Limited

AGM Statement and Trading Update

At the Company's Annual General Meeting to be held today, Peter Sheldon, Chairman of BATM, will make the following statement:

I would like to take this opportunity of giving shareholders an up-to-date report on the considerable progress made by the Company since the year end. I am very pleased to report that we are significantly exceeding our expectations within all parameters - trading and financial.

Growth has continued to be very strong and we confidently expect that revenues and operating profits for 2008 will be significantly higher than present market forecasts and our earlier expectations. Whilst it is too early in the year to give an accurate estimate, for the full year as a whole we anticipate exceeding current market forecasts of revenues of $110m, following last year's reported figure of $97 million, by at least a further $10 million, with a corresponding increase in forecast operating and net profits. 

This outcome is being achieved despite a background of widespread economic uncertainty and the considerable strengthening of the Israeli Shekel against all of the currencies in which we trade, especially the US$ and Euro.

We have also started to extend our intellectual property and technological expertise into new niche areas of opportunity. We have made a small number of investments in developing businesses, primarily in Eastern Europe (CIS and Balkans), where we see added value for the Company. Our main focus is in the field of IP controllers and associated management software for medical instruments and the distribution channels for those products. Our investments to date have been modest and have been financed entirely from our positive cash flow. We expect them to make a positive contribution to our performance this year and to grow substantially next year and beyond, adding a new dimension to BATM and its future prospects. 

I hope that shareholders will recognise the fast and accelerating progress that we are making in our traditional field of telecommunications, based on firm relationships with our customers, together with the exciting prospects offered by our new initiatives.

I would like to congratulate our whole BATM team for their dedication; enterprise; expertise and innovation that is an essential element in the achievement of the excellent position that the Company now enjoys.

Enquiries:

 

BATM Advanced Communications

+972 9866 2525

Dr Zvi Marom, Chief Executive

 

 

 

Threadneedle Communications

020 7936 9606

Josh Royston / Graham Herring

Kaupthing Singer & Friedlander

Nicholas How / Marc Young

020 3205 7620

Shore Capital

Graham Shore

020 7408 4090

About BATM Advanced Communications

BATM is a world leader in the design and supply of IP packet-based systems such as high-capacity, self-routing switches with extensive QoS capabilities. For more information, visit the BATM Advanced Communications web site at www.batm.com 

Telco Systems is a wholly owned subsidiary of BATM Advanced Communications Based in FoxboroMassachusetts; the company provides industry-leading networking solutions to the carrier and enterprise markets. Telco Systems' focus is to maximize the power of customers' networks by integrating transport, access, and packet technologies onto industry-leading platforms, therefore fully meeting today's and tomorrow's network requirements. For more information, visit the Telco Systems web site at www.telco.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFJMMTMMABBAP
Date   Source Headline
14th Apr 20229:30 amRNSAnnual Financial Report
13th Apr 20227:00 amRNSAppointment of Non-Executive Director
4th Apr 20227:00 amRNSTransaction in Own Shares and TVR
18th Mar 20227:00 amRNSStrategic Partnership for Edgility with NEXCOM
17th Mar 202210:30 amRNSResult of General Meeting
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 202211:30 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSFull Year Results
23rd Feb 20227:00 amRNSNotice of General Meeting
21st Feb 20227:00 amRNSStrategic Partnership for Edgility with Advantech
17th Feb 20227:00 amRNSTrading Update and Notice of Results
3rd Feb 202211:23 amRNSClarification on FTSE Nationality Review
3rd Feb 20227:00 amRNSUpdate on FTSE Nationality Review & Share Buyback
31st Jan 20227:00 amRNSUpdate on Ador Diagnostics
17th Jan 20227:00 amRNSUpdate on FTSE Nationality Review
4th Jan 20227:00 amRNSDividend Declaration
4th Jan 20227:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSFirst sales of rapid COVID-19 test in Russia
14th Dec 202111:45 amRNSResult of AGM and Dividend Declaration
30th Nov 20217:00 amRNSCOVID-19 tests effective in diagnosing Omicron
25th Nov 20213:00 pmRNSBlock Listing Interim Review
22nd Nov 20213:00 pmRNSNotice of AGM and Dividend Declaration
10th Nov 20217:00 amRNSBATM receives $3.5m cyber security contract
3rd Nov 20217:00 amRNSNew five-year contract for Edgility
1st Nov 20217:00 amRNSBATM receives agri-waste contract in Botswana
7th Oct 20217:00 amRNSStrategic partnership for NFV with AudioCodes
13th Sep 20217:00 amRNSFirst enterprise customer for NFV with $2m order
23rd Aug 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSNotice of Results
12th Jul 20217:00 amRNSLaunch of Edgility networking NFV-based ecosystem
5th Jul 20217:00 amRNSBATM receives $10m cyber security contract
15th Jun 20217:00 amRNSBATM receives $4.1m cyber security contract
26th May 20217:00 amRNSBlock listing Interim Review
18th May 20217:00 amRNSBATM commences delivery of new COVID-19 tests
19th Apr 202110:25 amRNSAnnual Financial Report
12th Apr 20217:00 amRNSStrategic partnership for NFV
29th Mar 20217:00 amRNSBATM develops molecular diagnostics test for TB
19th Mar 20217:00 amRNSCompletion of Sale of NGSoft
11th Mar 20217:00 amRNSBATM launches no-swab saliva-based COVID-19 test
1st Mar 20217:00 amRNSUpdate on Sale of NGSoft
22nd Feb 20217:00 amRNSFull Year Results
11th Feb 20215:38 pmRNSFTSE Nationality Review
1st Feb 20217:00 amRNSTrading Update and Notice of Results
19th Jan 20217:00 amRNSBATM's NFVTime now available for the public cloud
12th Jan 20217:00 amRNSBATM enters option agreement to sell NGSoft
24th Dec 20207:00 amRNSCOVID-19 test effective in diagnosing new strain
17th Dec 20203:50 pmRNSResult of AGM
15th Dec 20207:00 amRNSUpdate on Ador Diagnostics
7th Dec 20207:00 amRNSDelivery of First Insect Protein Recovery Facility
30th Nov 20203:03 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.